Spironolactone for Hair Loss in Women: Does It Work?

Medically reviewed by Jane Yoo, MD, board-certified dermatologist | Updated November 18th, 2026

Spironolactone is one of the most commonly prescribed treatments for female pattern hair loss, yet it was never approved for hair loss. It is a blood-pressure and fluid medication that also blocks androgen receptors, and dermatologists have been using it off-label for years. This page explains what it can and cannot do.

How it works

In susceptible follicles, androgens such as dihydrotestosterone contribute to miniaturization. Spironolactone reduces the effect of androgens by blocking their receptors and modestly lowering androgen production. That is why it is used for hormonal acne and excess hair growth as well as female pattern hair loss.

What the evidence shows

Studies, mostly small and observational, suggest that a meaningful share of women using spironolactone stabilize their hair loss, and some see improvement in density. The evidence base is more modest than for topical minoxidil, and high-quality randomized trials are limited. Improvement usually takes at least six months, so patience is required.

Who it is used for

  • Women with female pattern hair loss, especially those who also have hormonal acne or signs of androgen excess.
  • Women who want an option to pair with minoxidil.
  • Women who are not pregnant, not planning pregnancy, and using reliable contraception.

Side effects and safety

  • More frequent urination, dizziness or lightheadedness, especially early on.
  • Menstrual irregularities and breast tenderness.
  • Higher potassium levels, which is uncommon in healthy young women but more important with kidney disease or certain other medications. Whether and how often to check blood tests varies by clinician.
  • Pregnancy: spironolactone should not be used during pregnancy because it can affect the development of a male fetus.
  • Drug interactions: let your clinician know about potassium supplements, ACE inhibitors, ARBs and NSAIDs.

Spironolactone and minoxidil together

Some clinicians combine low-dose oral minoxidil with spironolactone. Part of the rationale is that spironolactone may reduce the excess body hair that oral minoxidil can cause. This approach is off-label, prescription only, and best managed by a clinician who can monitor blood pressure and side effects.

What about finasteride or dutasteride?

These are other anti-androgen approaches, but they are generally avoided in women who could become pregnant, and the evidence in women is limited. Some physicians use them off-label in selected postmenopausal women. See our guide to finasteride and dutasteride.

The practical bottom line

Spironolactone is a reasonable, widely used option for the right woman, and it works best as part of a plan rather than a standalone fix. It is not for everyone, and it needs a clinician to review your medical history, medications and pregnancy plans before you start.

—

Frequently asked questions

How long does spironolactone take to work for hair loss?

Plan on at least six months before judging results, with benefit continuing to build for up to a year. Hair loss often resumes if treatment is stopped.

Is spironolactone safe during pregnancy?

No. It should not be used during pregnancy because it can affect the development of a male fetus. Reliable contraception is needed while taking it.

Can I take spironolactone and minoxidil together?

Many dermatologists do combine them. Both are off-label when used together for hair loss, so a clinician should supervise, including monitoring blood pressure and side effects.

—

Concerned about hair thinning or shedding? Dr. Jane Yoo is a board-certified dermatologist in Midtown Manhattan. A proper diagnosis comes first, because the right treatment depends on the type of hair loss. Book a consultation.

This article is for educational purposes and does not replace an in-person medical evaluation.


author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.